Cervical Cancer by FIGO Stage 2018 — Trials

Cervical Cancer by FIGO Stage 2018 — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Institut Paoli-Calmettes
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07461142	Reduction of Hematologic Toxicity in Locally Advanced Cervical Cancers(RETHEMCOL)	not yet recruiting	N/A	72	Institut Paoli-CalmettesOTHER	0	Mar 10, 2026	clinicaltrials
NCT07368985	Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer	not yet recruiting	Phase 2	87	Prof. Dr. Remi A. NoutOTHER	1	Jan 27, 2026	clinicaltrials